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SHORT REPORT
The intestinal distribution pattern 
of appetite- and glucose regulatory peptides 
in mice, rats and pigs
Nicolai J. Wewer Albrechtsen† , Rune E. Kuhre†, Signe Toräng and Jens J. Holst*
Abstract 
Background: Mice, rats, and pigs are the three most used animal models when studying gastrointestinal peptide 
hormones; however their distribution from the duodenum to the distal colon has not been characterized systemati-
cally across mice, rats and pigs. We therefore performed a comparative distribution analysis of the tissue content of 
the major appetite- and glucose regulatory peptides: glucose-dependent insulinotropic polypeptide (GIP), glucagon-
like peptide-1 (GLP-1), glucagon-like peptide-1 (GLP-2), oxyntomodulin/glicentin, neurotensin, and peptide YY (PYY) 
from the duodenum to distal colon in mice (n = 9), rats (n = 9) and pigs (n = 8), using validated radioimmunoassays.
Results: GLP-1, GLP-2 and oxyntomodulin/glicentin show similar patterns of distribution within the respective spe-
cies, but for rats and pigs the highest levels were found in the distal small intestine, whereas for the mouse the high-
est level was found in the distal colon. In rats and pigs, neurotensin was predominantly detected in mid and lower 
part of the small intestine, while the mouse showed the highest levels in the distal small intestine. In contrast, the 
distribution of GIP was restricted to the proximal small intestine in all three species. Most surprisingly, in the pig PYY 
was found in large amounts in the proximal part of the small intestine whereas both rats and mice had undetectable 
levels until the distal small intestine.
Conclusions: In summary, the distribution patterns of extractable GIP, GLP-1, GLP-2, oxyntomodulin/glicentin, neu-
rotensin are preserved across species whereas PYY distribution showed marked differences.
Keywords: Gut hormones, Gastrointestinal tract, Distribution of gut hormones in the mouse rat and pig
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Background
The gastrointestinal tract plays a key role for the regula-
tion of appetite and blood glucose [1–3]. This is partly 
due to the secretion of the proglucagon (pcg) derived gut 
hormones: glucagon-like peptide 1 (GLP-1), glucagon-
like peptide 2 (GLP-2), oxyntomodulin/glicentin; as well 
as non-pcg derived peptides: glucose-dependent insuli-
notropic peptide (GIP), neurotensin (NT), and peptide 
YY (PYY), all of which inhibit appetite [2], while some, in 
addition, potentiate glucose-stimulated insulin secretion 
(GIP and GLP-1) or suppress glucagon secretion (GLP-
1) [4]. The distribution of gut hormones along the gas-
trointestinal tract in mice, rats, and pigs has primarily 
been assessed by immunohistochemistry and/or mes-
senger RNA (mRNA) determination, but these may not 
always be reliable surrogate markers for protein content 
and thereby secretion [5]. Potential discrepancies may 
therefore be related to the validity of the method used for 
assessing the distribution of appetite- and glucose regu-
lating peptides. In the case of immunohistochemistry, 
the specificity of antisera used [6], the tissue preparation, 
antigen retrieval, thresholds for positive and negative 
signal may interfere with interpretation of intestinal dis-
tribution patterns [7–9]. With regards to the validity of 
mRNA data this indeed depends on primer specificity 
but also on post-transcriptional regulation such as the 
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regulation by micro RNAs [10, 11], and of course also on 
the usual reliability criteria regarding precision/sensitiv-
ity and accuracy.
Mice, rats, and pigs are the three most used model ani-
mals in enteroendocrine research [12], but their resem-
blance to one another with respect to their intestinal 
distribution of appetite- and glucose regulatory pep-
tides has not been investigated systematically [13]. In the 
current study we used well characterized radioimmu-
noassays, previously validated according to the guidelines 
by Clinical and Laboratory Standards Institute [14–19], 
to perform an in-depth distribution analysis of six appe-
tite- and glucose regulatory peptides, hypothesizing that 
the distribution profiles for these peptides may differ 
across species due to their different patterns of feeding; 
rodents being “nibblers” and coprophagic, while pigs like 
humans are omnivores and tend to eat fewer and larger 
meals.
Methods
Tissue
Studies were carried out with permission from the 
Danish Animal Experiments Inspectorate (2013-15-
2934-00833) and in accordance with the EU Directive 
2010/63/EU and guidelines of Danish legislation gov-
erning animal experimentation (1987) and the National 
Institutes of Health (publication number 85-23). Tissue 
was harvested at 8–11 AM for all species which were 
obtained during previous study [20] investigating the 
amidation efficiency of GLP-1. Non-fasted Wistar rats 
(weight  =  274.3  ±  11.7  g; n  =  9) (Taconic, Ejby, Den-
mark) were anesthetized by subcutaneous injection with 
Hypnorm®/Midazolam® (0.2  ml/100  g, conc. 5  mg/ml) 
and tissue samples (≈1.5 cm/piece) were collected from 
duodenum, proximal jejunum, distal ileum, caecum, 
proximal colon and distal colon. Thereafter, the rats were 
euthanized by diaphragm perforation. Non-fasted male 
C57bl/6 mice (weight = 30 ± 5 g; n = 9) (Charles River 
Laboratories International, Inc., Erkrath, USA) were sac-
rificed by cervical dislocation and tissue samples (≈3 cm/
piece) were collected from regions corresponding to 
those of the rats. Porcine tissue was collected from ani-
mals of the LYY strain n = 8). Food was withdrawn 24 h 
before surgery, but animals had free access to drinking 
water. After premedication with ketamine and induc-
tion with pentobarbital, animals were anesthetized with 
α-chloralose (66 mg/kg) and ventilated with intermittent 
positive pressure. Tissue (1 cm/piece) was collected from 
same regions as the rat and mouse. The pigs were sacri-
ficed by pentobarbital. For all species, all tissues were 
thoroughly rinsed in cold PBS, snap frozen on dry ice and 
stored at −80 °C until protein extraction.. The anatomical 
definitions in mice, rats and pigs are shown in Table 1.
In present study we tested two different protein extrac-
tion methods (trifluoroacetic acid and formic acid), 
several reconstitution buffers and dilution factors for 
optimization of the subsequent measurements by radio-
immunoassays. The extracts were purified using pH 
resistant tc18 cartridges (Cat. no. WAT036810, Waters, 
MA, USA), dried under a gentle stream of compressed 
air overnight and reconstituted in 1  mL of TRIS buffer; 
100  mmol/l TRIS buffer (Cat. no. T-3253 and T1503, 
Sigma Aldrich) supplemented with 0.1  % (w/v) human 
serum albumin (Cat. no. 12666, Merck KGaA, Darm-
stadt, Germany), 20 mmol/l EDTA and 0.6 mmol/l Thi-
merosal (Cat. no. T-5125, Sigma Chemical Co., St. Louis, 
MO, USA) (pH = 8.5), and further diluted in assay buffer 
to ensure that the measured concentrations were within 
the detection range of the respective standard curves.
Biochemical measurements
Amidated GLP-1, intact GLP-2, total neurotensin, total 
PYY, and intact GIP levels were measured with well char-
acterised in-house developed RIAs validated according 
to the Clinical and Laboratory Standards Institute Proto-
cols as described [17, 19–22]. For simultaneous measure-
ments of oxyntomodulin/glicentin we used an in-house 
developed C-terminus specific RIA assay with equal 
recoveries (98  ±  11  %) of oxyntomodulin and glicentin 
as described previously [14]. The RIAs have inter-assay 
variations of <15 %, intra-assay variations of 5–10 % and 
their specificity, sensitivity and precision has been tested 
Table 1 Definitions of intestinal segments
The anatomical definitions shown above have previously been published by Kuhre et al. [20]
Wistar rat C57bl/6/mouse LYY strain pig
Duodenum 0.5 cm after pyloric sphincter 0–3 cm after pyloric sphincter 5 cm after pyloric sphincter
Prox. Jejunum 6 cm after pyloric sphincter 3 cm after pyloric sphincter 50 cm after pyloric sphincter
Dist. ileum 0.5 cm before the ileo-cecal junction 0.5 cm before the ileo-cecal junction 10 cm before the ileo-cecal junction
Caecum Mid part of caecum Mid part of caecum Mid part of caecum
Prox. colon 0.5 cm after colon connects to caecum First 5 cm of colon 10 cm after caecum
Dist. colon 0.5 cm before rectum 0.5 cm before rectum 10 cm before rectum
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according to the criteria of Richterich as described [15, 
16].
Statistics analysis
Data are presented as mean relative fold variation ±1 
SEM, relative to the overall average of peptide content 
across (pmol/g) all intestinal segments in the respective 
species. Raw data (pmol/g) are shown in Additional file 1: 
Table S1. Overall average was calculated on the basis of 
the measured peptide concentrations, the dilution factor 
employed and the weight of the respective biopsies and 
expressed in pmol/g. Differences in segmental hormone 
concentrations were evaluated by one-way ANOVA for 
repeated measurements corrected for multiple testing by 
Bonferroni post hoc analysis. P < 0.05 was considered sig-
nificant. Prior to the statistical test, normality and homo-
scedasticity in datasets were tested by both Shapiro–Wilk 
test (swilk command) and visually from residual plots. 
Calculations and figures were prepared using GraphPad 
Prism, GraphPad Software, La Jolla California USA.
Results
GLP‑1, GLP‑2 and oxyntomodulin/glicentin
Levels of amidated GLP-1 increased significantly (Fig. 1a, 
P  <  0.01) along the gastrointestinal tract in the mouse, 
whereas in the rat the highest levels were found in the 
distal ileum. In the pig, similar concentrations were 
found from distal ileum to distal colon, but nothing was 
detected in the duodenum or the proximal jejunum 
(Fig.  1a). GLP-2 showed similar patterns of distribution 
as GLP-1, although for the pig, GLP-2 levels were signifi-
cantly lower (Fig. 1b, P < 0.05) in the colon compared to 
the small intestine. Oxyntomodulin/glicentin patterns 
paralleled GLP-2 levels in all three species (Fig. 1c).
GIP, neurotensin and PYY
Profiles of GIP levels along the gastrointestinal tract were 
similar across all three species (Fig.  2a). Highest con-
centrations were found in the proximal jejunum with 
decreasing concentrations in the subsequent anatomical 
segments down the intestine. In contrast, the concentra-
tions of neurotensin varied between mouse, rat and pig 
(Fig. 2b). In the rat and pig, highest levels were found in 
the distal ileum, whereas the mouse had similar levels in 
the distal ileum and the proximal colon. PYY levels con-
tinued to increase along the gastrointestinal tract of the 
mouse, with highest levels in the distal colon, whereas in 
the pig, PYY levels are shifted towards the small intestine 
(Fig. 2c). Finally, in the rat, PYY levels were below detec-
tion in the proximal small intestine (duodenum and prox-
imal jejunum) with the highest levels found in the distal 
ileum and about half of that in the remaining anatomical 
sections.
Discussion
Our analysis demonstrates that while distribution of GLP-
1, GLP-2, oxyntomodulin/glicentin, neurotensin, and 
GIP is relatively preserved across species, the anorectic 
hormone PYY, to our surprise, showed marked interspe-
cies differences (Figs.  1, 2). In contrast, previous studies 
using gene expression, immunohistochemistry or RIA 
reported low (or no) expression of PYY in the proximal 
small intestine in the pig [13, 23, 24]. However, Cho et al. 
recently suggested that differences across pig strains may 
occur [25]. We are unable to determine from the present 
results whether this is relevant for our data (with material 
obtained from pigs of the Danish LYY/LYD strain). For the 
rat, the peptide was undetectable in the proximal small 
b
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Fig. 1 Tissue concentration of GLP-1, GLP-2 and GLI/OX in mouse, 
rat and pig. Distribution of proglucagon derived peptides along the 
gastrointestinal tract in mice, rats and pigs. Data are shown as relative 
means ± 1SEM (compared to overall average for the respective spe-
cies). a GLP-1 total, b GLP-2 (intact) and GLI/OX (total) for duodenum 
(D), proximal jejunum, (PJ), distal ileum (DI), caecum (C), proximal 
colon (PC) and distal colon (DC). Significance is indicated above 
respective bars. Significant different (P < 0.05) from a duodenum, b 
proximal jejunum, c distal ileum, d caecum, e proximal colon and f 
distal colon
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intestine (Table 1), in both diluted and undiluted extracts 
(data not shown for latter), and concentrations increased 
from distal ileum to distal colon. Based on the sensitivity 
of the assay used for measuring PYY (lower limit of detec-
tion ~1.5 ± 0.1 pmol/l) and a post hoc power calculation 
(one sided student t test, comparing the reference values 
and variations to the lower limit of detection with alpha 
value of 0.05 yielding an estimated a power of 89.75 %), we 
find it unlikely that this observation is the result of a type 
2 error. The rat also had no detectable PYY stored in the 
proximal small intestine whereas the highest concentra-
tion was found in distal ileum, although appreciable con-
centrations were also detected in the large intestine. This 
is partly in agreement with other studies that have found 
increasing amounts of PYY distally along the gastro-
intestinal tract in man, monkey, rat and mouse [5, 24–29]. 
Interestingly, the pig showed a complete different pattern 
of PYY storage compared to the mouse and rat (Fig.  2) 
and to that described for humans [29]. In pigs, PYY was 
stored in the entire small intestine in concentrations that 
were comparable to that found in distal colon, while very 
little was detected in the caecum and proximal colon.
With regards to the distribution pattern of the progluca-
gon derived peptides: GLP-1, GLP-2 and oxyntomodulin/
glicentin, all three of them closely mirrored each other 
(equimolar amounts), as would be expected given that 
they are derived from the same precursor (although pro-
hormone processing might differ) [30]. Nevertheless, in 
the pig, GLP-2 levels decreased along the colon compared 
to the mouse and rat. To our knowledge, this has not been 
reported in other studies [31]. Similar findings, although 
not as extensively examined, have been reported for 
humans [32]. However, while the concentration of these 
peptides progressively increased from duodenum towards 
distal colon in the mouse, the highest concentrations in 
rat and pig were found in distal ileum, caecum, and proxi-
mal colon with little or no detectable concentrations in 
proximal small intestine. A similar, scattered distribution 
of GLP-1, GLP-2, and oxyntomodulin/glicentin has previ-
ously been reported using immunohistochemistry [23, 33].
In rats and pigs, neurotensin was predominantly stored 
in the mid and distal part of the small intestine with little 
or no measureable peptide in the large intestine (Fig. 2), 
while the mouse had the highest neurotensin concentra-
tions in the distal ileum and proximal colon, in agree-
ment with another study in rats and humans [34]. Our 
study does have several limitations: we did not character-
ize the cellular origin of the peptides of interest and we 
cannot exclude that some variation may exist between 
strains of the tested animals. Therefore we chose to char-
acterize frequently used strains of the respective animals 
to increase the relevance of our findings.
In summary, the mouse conforms with the classical 
assumption that levels of enteroendocrine hormones 
increase along the gastrointestinal tract [35], whereas 
the rat and particular the pig may differ—at least when 
estimated by quantification of extractable tissue peptide 
contents. However, also peptide content may not neces-
sary reflect secretory output/capacity, as indicated by 
a recent study from our group [5]. Another important 
observation in this study is that while the tissue concen-
trations of GLP-1 and PYY parallel each other closely in 
the mouse and rat, this was not the case for the pig. In 
this case, high concentrations of PYY are found in the 
proximal small intestine where little or no GLP-1 was 
detected. It is generally believed that PYY is co-produced 
and co-secreted with GLP-1 in distal L-cells of the small 
intestine and large intestine in rats [5, 26], mouse [27, 36] 
and humans [27, 32, 37]. Given that GLP-1 excursions 
typically peak around 30–60  min after meal intake in 
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Fig. 2 Tissue concentration of GIP, NT and PYY in mouse, rat and 
pig. Data are shown as relative means ± 1SEM (compared to overall 
average for the respective species). a GIP total, B: NT (intact) and PYY 
(total) from duodenum (D), proximal jejunum, (PJ), distal ileum (DI), 
caecum (C), proximal colon (PC) and distal colon (DC). Significance are 
indicated above respective bars. Significant different (P < 0.05) from a 
duodenum, b proximal jejunum, c distal ileum, d caecum, e proximal 
colon and f distal colon
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humans (and faster in rodents), it remains a mystery why 
the concentration of GLP-1 is so high in the distal part of 
the gastrointestinal tract. Several hypotheses exists; both 
GLP-1 and GLP-2 have been shown to enhance growth of 
the intestinal mucosa [38], suggesting that the high dis-
tal concentration of these peptides may play a role in the 
adaptative regulation of the growth of the colonic epithe-
lium. Based on the observation that GIP can stimulate 
GLP-1 secretion from the L-cell model line GLUTag it 
has been suggested that the distally located L-cell may be 
activated by circulating GIP (which are rapidly released 
upon meal intake), thereby enabling distally located 
L-cells to contribute to the GLP-1 response long before 
luminal chyme has reached these cells [39]. However, in 
perfused pig ileum, only supra-physiological concentra-
tions of GIP stimulated GLP-1 secretion [40] and even 
rather high doses of GIP do not stimulate GLP.1 secretion 
in humans [41]. Noteworthy, our study, however, indi-
rectly indicates that, at least in case of the LYY/LYD pig, 
PYY may be produced by a different enteroendocrine cell 
than the classical L-cell. Finally, it would be of substan-
tial interest to determine which of the three species has 
the “highest” similarity to humans in respect distribution 
of gut hormones along the GI tract. Unfortunately, to the 
best of our knowledge, currently, a similar comparative 
human study on the distribution of gut hormones along 
the gastro-intestinal tract does not exist. Therefore, the 
only insight that can be gained on this matter depends 
on scanty evidence from 30 years old literature [35, 42], 
where analytical specificity may have been questionable. 
Future studies investigating the human gastrointestinal 
tract by both mRNA, peptide content, and immunohisto-
chemistry may provide new and important knowledge of 
the complex endocrine system allowing a qualified deci-
sion regarding the best animal model for humans. Taken 
together, our findings conform to our hypothesis; that the 
distribution of glucose and appetite regulating hormones 
are similar in rodents (rats and mice) but different in pigs, 
in particular in respect to the proximal small intestine. 
Perhaps these differences may be explained by variance 
in feeding patterns observed between rodents and pigs.
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